Skip to Content

ZA-35 37.5 mg (Venlafaxine Extended Release 37.5 mg)

Pill with imprint ZA-35 37.5 mg is Gray & White, Capsule-shape and has been identified as Venlafaxine hydrochloride extended release 37.5 mg. It is supplied by Zydus Pharmaceuticals USA Inc..

Venlafaxine is used in the treatment of major depressive disorder; anxiety; depression; autism; anxiety and stress (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 37.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for ZA-35 37.5 mg

Venlafaxine hydrochloride extended release

ZA-35 37.5 mg
37.5 mg
Gray & White
Prescription only
Drug Class:
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Zydus Pharmaceuticals USA Inc.
Inactive Ingredients:
silicon dioxide
cetostearyl alcohol
microcrystalline cellulose
ethyl acrylate - methyl methacrylate copolymer
sodium lauryl sulfate
magnesium silicate
titanium dioxide
ferrosoferric oxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
60429-0121 Golden State Medical Supply (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.